All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
(September 16 09:04) NDTV News
Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.